Evaluation of the PrePex Device for Rapid Scale-up of VMMC, Phase 3 Field Implementation Trial With HIV + Adult Males

Inclusion Criteria: * Agrees to take an HIV test * HIV sero-positive * WHO HIV clinical stage 1 or 2 * Age 18 years and above * Agrees to be circumcised by PrePex * Able to understand the study procedures and requirements * Completes VMMC counseling * Agrees to return to the health care facility for follow-up visits or as instructed after this circumcision until complete healing 7 weeks from device application, or until cleared by a physician * Able to comprehend and freely give informed consent for study participation Exclusion Criteria: * Known bleeding/coagulation abnormality (excessive bleeding from nosebleeds, pulled tooth, or gums) * Uncontrolled diabetes (frequent treatment in a clinic or recent hospitalization for diabetes, frequent infections, hypertension, or kidney disease) * Active genital infection, anatomic abnormality or any other condition, which in the opinion of the investigator prevents the subject from undergoing circumcision using PrePex. * HIV sero-negative * HIV status unknown * WHO HIV stage 3 and above * Does not agree to PrePex